Thursday, December 19, 2019 2:35:11 PM
Postings by trader53 to KYN Capital Group Inc.
https://investorshub.advfn.com/boards/memberpoststoboard.aspx?userid=155361&boardid=14384
________________________________________________________________
Market Maker Signals - Explained
________________________________________________________________
Market Maker Signals
Penny traders believe that Market Makers (MM)
will "signal" moves in advance buy using
small amounts of buys or sells as "signals".
The "signals" are such a small amount of shares
(worth no more than 5 or 10 dollars) that
no trader would have paid a commission that
costs more than the amount of shares bought.
The "signals" are from one MM to another.
100 - I need shares.
200 - I need shares badly, but do not take the stock down.
300 - Take the price down so I can load shares
400 - Keep trading it sideways.
500 - Gap the stock.
This gap can be either up or down,
depending on the direction of the 500 signal.
505 - I am short on shares
600 - Means provide resistance
900 - Means let the stock float
911 - Pending News/Press Release On The Way
1000 - Don't let it run
2100 - Let it run
http://www.pennystockdream.com/Market-Maker-Signals
Understanding the Form T-Trade:
If a market maker wants to accumulate
a large amount of a stock in one trading day,
that market maker may actually not report
any of the trades that occurred
until the trading day has ended
so as not to alert the market to the collection.
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=120820833&txt2find=understanding
________________________________________________________________
________________________________________________________________
KYNC - Time & Sales
http://www.investorpoint.com/stock/KYNC-KYN+Capital+Group+Inc/market-makers-level2/
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM